ROIVANT SCIENCES LTD. Investments, Fair Value Disclosure
ROIVANT SCIENCES LTD. (ROIV) had Investments, Fair Value Disclosure of $444.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2026-08-06
- 2026-06-30: Investments, Fair Value Disclosure $444.62M.
- 2026-03-31: Investments, Fair Value Disclosure $407.99M.
- 2025-12-31: Investments, Fair Value Disclosure $433.91M.
- 2025-09-30: Investments, Fair Value Disclosure $412.31M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $444.62M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $407.99M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $433.91M 10-Q · filed 2026-02-06 |
| 2025-09-30 | $412.31M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $283.81M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $302.94M 10-K · filed 2026-05-20 |
| 2024-12-31 | $290.04M 10-Q · filed 2025-02-10 |
| 2024-09-30 | $311.35M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $262.98M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $247.75M 10-K · filed 2025-05-29 |
| 2023-12-31 | $239.93M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $250.39M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $296.24M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $304.32M 10-K · filed 2024-05-30 |
| 2022-12-31 | $272.47M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $246.61M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $301.29M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $325.83M 10-K · filed 2023-06-28 |
| 2021-12-31 | $398.74M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $436.78M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $180.36M 10-Q · filed 2021-09-21 |
| 2021-03-31 | $188.98M 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |